Psiac Online

Literaturverzeichnis


Wilner et al. Biol Psychiatry (1991) 29, 354S[2298]
Wilner KD, DeMattos SB, Anziano RJ, Apseloff G, Gerber N. Lack of CYP 2D6 inhibition by ziprasidone in healthy volunteers. Biol Psychiary (1997) 42, 42S[2495]
Wilner KD, Hansen RA, Folger CJ, Geoffroy P. The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid. Br J Clin Pharmacol (2000) 49 (Suppl1), 57S-60S[2493]
Wilson et al. N Engl J Med (1970) 282, 1063-1067[1590]
Windorfer A Jr. Neuropadiatrie. Feb 1977; 8(1): 29-41 Pubmed[1048]
Wingård L. J Affect Disord. Aug 2017; 217: 16-23 Pubmed[4592]
Winsemius A. J Clin Pharmacol. Sep 2014; 54(9): 1038-47 Pubmed[3960]
Winter HR. Drug Metab Dispos. Aug 2000; 28(8): 865-8 Pubmed[4453]
Winter HR. Hum Psychopharmacol. Oct 2007; 22(7): 469-76 Pubmed[2826]
Winton JC. Am J Med Sci. Feb 2013; 345(2): 160-2 Pubmed[3859]
Wiśniowska B. BMC Pharmacol Toxicol. Mar 2016; 17: 12 Pubmed, Volltext, DOI[4300]
Witt et al. Ann Pharmacother (1993) 27, 1463-4[786]
Wittmann et al. Neuro Endocrinol Lett. 2010 Apr 29;31(2):203-207[2210]
WITTON K. Am J Psychiatry. Feb 1965; 121: 812-3 Pubmed[573]
Wodak J. Med J Aust. Dec 1972; 2(23): 1277-82 Pubmed[1265]
Woelk H. Phytomedicine. Feb 2010; 17(2): 94-9 Pubmed[3638]
Wójcikowski et al. Pharmacol Rep. 2009 Sep-Oct;61(5):851-8[1822]
Wójcikowski J. Biochem Pharmacol. Jul 2014; 90(2): 188-95 Pubmed[145]
Wójcikowski J. Biochem Pharmacol. Oct 2010; 80(8): 1252-9 Pubmed[90]
Wójcikowski J. Br J Pharmacol. Apr 2003; 138(8): 1465-74 Pubmed, Volltext, Nature[2270]
Wójcikowski J. Drug Metab Dispos. Mar 2006; 34(3): 471-6 Pubmed[214]
Wójcikowski J. Eur Neuropsychopharmacol. May 2004; 14(3): 199-208 Pubmed[177]
Wójcikowski J. Pharmacol Rep. Dec 2014; 66(6): 1122-6 Pubmed[1481]
Wójcikowski J. Pharmacol Rep. Sep 2009; 61(5): 851-8 Pubmed[422]
Wójcikowski J. Pol J Pharmacol. Jul 2002; 54(4): 407-10 Pubmed[1178]
Wójcikowski, Daniel. Pharmacol Rep. 2009 Sep-Oct;61(5):851-8[2074]
Wojtczak A. Pharmacol Rep. Jun 2014; 66(3): 511-4 Pubmed[1441]
Wolf (2006) Drugs Res Dev 7:163-172[2794]
Wong et al. (1997) Schizophr Res 24, 200-201[2211]
Wong KE. Singapore Med J. Oct 1990; 31(5): 432-3 Pubmed[844]
Wong MC, Suite NDA, Labar DR. Seizures in human immunodeficiency virus infection. Arch Neurol 1990; 47: 640–42[2564]
Wong SL. Clin Pharmacol Ther. Jul 1996; 60(1): 48-53 Pubmed[2420]
Wong SL. Eur J Clin Pharmacol. Jan 1997; 52(3): 223-7 Pubmed[201]
Wong SL. Int J Clin Pharmacol Ther. Mar 1998; 36(3): 146-51 Pubmed[436]
Wong SL. J Clin Pharmacol. Nov 1997; 37(11): 1056-61 Pubmed[2997]
Wong YN. J Clin Pharmacol. Mar 1999; 39(3): 281-8 Pubmed[163]
Wong YWF, Ewing BJ, Thyrum PT, Yeh C. The effect of phenytoin and cimetidine on the pharmacokinetics of Seroquel. Schizophr Res (1997) 24, 200-1[2216]
Wong YWJ, Yeh C, Thyrum PT. The effects of concomitant phenytoin administration on the steady-state pharmcokinetics of quetiapine. J Clin Psychopharmacol (2001) 21, 89-93[2231]
Wood et al. Circulation (1980) 62, 119-22[1262]
Wood SG. Ann Allergy. Dec 1987; 59(6 Pt 2): 31-4 Pubmed[346]
Wright CE. Pharmacotherapy. Jan 1992; 12(2): 103-6 Pubmed[1395]
Wrishko RE. J Clin Pharmacol. May 2008; 48(5): 610-8 Pubmed[445]
Wu CC. Ther Drug Monit. Oct 2016; 38(5): 587-92 Pubmed[2446]
Wu D. Br J Clin Pharmacol. Jan 1993; 35(1): 30-4 Pubmed, Volltext[3845]
Wu et al. J Chin Med Assoc. 2009 Aug;72(8):446-449[1928]
Wuttke H. Dtsch Med Wochenschr. Apr 2004; 129(15): 831-5 Pubmed[834]
www.drug-interaction.com[702]
www.GENEMEDRX.COM, P450 Drug Interactions, Created and maintained by Jessica Oesterheld, Contributing Editors: David N. Osser, M.D, Neil B. Sandson, M.D., Gabriel Eckermann, M.D[2593]
Wyeth (UK). Personal communication, September 2001[744]
Wynala & Wienkers. Drug Metab Disp 1997;25(10):1211-1214[1825]
Wynalda MA. Drug Metab Dispos. Jul 2003; 31(7): 878-87 Pubmed[3281]
Wynalda MA. Drug Metab Dispos. Oct 1997; 25(10): 1211-4 Pubmed[370]
Wynalda MA. Drug Metab Dispos. Sep 2000; 28(9): 1014-7 Pubmed[3773]
Wynchank D. Hum Psychopharmacol. Jun 2003; 18(4): 271-5 Pubmed[1936]
Wynn et al. Clinical Manual of Drug Interaction. Principles for medical practice , American Psychiatric Publishing, Washington DC (2009)[2915]
Wynn et al. Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009)[3059]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice , American Psychiatric Publishing, Washington DC (2009[2942]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice , American Psychiatric Publishing, Washington DC (2009)[2909]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009)[3119]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009), p 272[3126]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009), Rifampicin S. 580-581 (Index)[3627]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009), S. 161[3651]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009), S. 585 (Index)[3591]
Wynn GH, Oesterheld JR, Cozza KL, Amstrong SC, Clinical Manual of Drug Interaction. Principles for medical practice, American Psychiatric Publishing, Washington DC (2009), S. 585 St. John´s wort (Index)[3676]
Xiang Q. J Clin Pharmacol. Jun 2010; 50(6): 659-66 Pubmed[194]
Xin H. Aliment Pharmacol Ther. May 2005; 21(9): 1105-9 Pubmed[4088]
Xiong GL. J Clin Psychopharmacol. Aug 2008; 28(4): 472-3 Pubmed[2001]
Xu BB. Pharmazie. Jan 2014; 69(1): 43-7 Pubmed[4383]
Xu RA. Pharmazie. May 2013; 68(5): 365-8 Pubmed[353]
Yamada S. Drug Metab Dispos. Aug 2010; 38(8): 1314-21 Pubmed[348]
Yamada S. Ther Drug Monit. Dec 2009; 31(6): 764-8 Pubmed[2975]
Yamamoto T. Xenobiotica. Aug 2003; 33(8): 823-39 Pubmed[32]
Yamaya M. Nihon Kokyuki Gakkai Zasshi. Jan 2002; 40(1): 3-10 Pubmed[3794]
Yamazaki H. Chem Res Toxicol. Jun 1998; 11(6): 659-65 Pubmed[4673]
Yamazaki H. Drug Metab Dispos. Nov 1998; 26(11): 1053-7 Pubmed[434]
Yamreudeewong W. Drug Saf. Jan 2003; 26(6): 421-38 Pubmed[4570]
Yan JH. J Clin Pharmacol. Nov 2006; 46(11): 1250-8 Pubmed[3444]
Yan KH. Oncol Rep. Sep 2013; 30(3): 1497-505 Pubmed[3955]
Yang BR. PLoS One. May 2015; 10(5): e0125180 Pubmed, Volltext, DOI[4053]
Yang FW. Gen Hosp Psychiatry. May 2011; 33(3): 302.e1-2 Pubmed[2242]
Yang TJ. Drug Metab Dispos. Jan 1999; 27(1): 102-9 Pubmed[109]
Yao C. J Clin Pharmacol. May 2005; 45(5): 519-28 Pubmed[2998]
Yap et al. Eur J Cancer Care (Engl). 2009 Dec 17[3141]
Yaryura-Tobias JA, Wolpert A, Dona L, Merlis S. Action of L-dopa in drug-induced extrapyramidalism. Dis Nerv Syst (1970) 1, 60-3[880]
Yaryura-Tobias JA. Dis Nerv Syst. Jan 1970; 31(1): 60-3 Pubmed[1447]
Yassa R. A case of lithium-chlorpromazine intraction. J Clin Psychiatry (1986) 47, 90-1[887]
Yasuda K. Drug Metab Dispos. Aug 2008; 36(8): 1689-97 Pubmed[4519]
Yasuda SU. Br J Clin Pharmacol. May 2002; 53(5): 519-25 Pubmed, Volltext, DOI[88]
Yasuhara M. J Pharmacobiodyn. Nov 1990; 13(11): 681-7 Pubmed[4183]
Yasui N, Otani K, Kaneko S, Ohkubo T, Osani T, Ishida M, Mihara K, Kondo T, Sugawara K, Fukushima Y. Inhibition of Trazodone metabolism by thioridazine in humans. Ther Drug Monit (1995) 17, 333-5[2076]
Yasui N. Int Clin Psychopharmacol. Jul 1997; 12(4): 225-9 Pubmed[724]
Yasui N. Psychopharmacology (Berl). Jun 2000; 150(2): 185-90 Pubmed[3184]
Yasui N. Psychopharmacology (Berl). Oct 1998; 139(3): 269-73 Pubmed[31]
Yasui N. Ther Drug Monit. Aug 1995; 17(4): 333-5 Pubmed[2386]
Yasui-Furukori N et al. Ther Drug Monit 2016 Epub ahead[4195]
Yasui-Furukori N. Eur J Clin Pharmacol. Jan 2007; 63(1): 51-6 Pubmed[2036]
Yasui-Furukori N. J Clin Psychopharmacol. Oct 2003; 23(5): 435-40 Pubmed[4665]
Yasui-Furukori N. Psychopharmacology (Berl). Jan 2004; 171(2): 223-7 Pubmed[1478]
Yasui-Furukori N. Ther Drug Monit. Feb 2007; 29(1): 45-8 Pubmed[2592]
Yasui-Furukori N. Ther Drug Monit. Oct 2013; 35(5): 649-52 Pubmed[2645]